Imported Disease Annotations - OMIMObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ABHD16A | Human | hereditary spastic paraplegia 86 | | IAGP | | 7240710 | | OMIM | | |
|
Imported Disease Annotations - OMIMObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ABHD16A | Human | hereditary spastic paraplegia 86 | | IAGP | | 7240710 | | OMIM | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | GOAs Human GO annotations | GOA_HUMAN data from the GO Consortium |
2. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
PMID:2813433 | PMID:2911734 | PMID:12477932 | PMID:12665801 | PMID:14574404 | PMID:14656967 | PMID:14667819 | PMID:14702039 | PMID:15231747 | PMID:15342556 | PMID:15489334 | PMID:15498874 |
PMID:17461779 | PMID:18835879 | PMID:19115949 | PMID:19116923 | PMID:19423540 | PMID:19851445 | PMID:20406964 | PMID:20438785 | PMID:20626023 | PMID:20706999 | PMID:21044367 | PMID:21516116 |
PMID:21873635 | PMID:22658674 | PMID:25290914 | PMID:25416956 | PMID:25580854 | PMID:26186194 | PMID:26496610 | PMID:27375898 | PMID:28514442 | PMID:29180619 | PMID:29794032 | PMID:29892012 |
PMID:31515488 | PMID:32296183 | PMID:32462874 | PMID:33845483 | PMID:33961781 | PMID:34587489 | PMID:34866177 | PMID:35337019 | PMID:36215168 | PMID:36217029 | PMID:36949045 |
ABHD16A (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abhd16a (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abhd16a (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abhd16a (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ABHD16A (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ABHD16A (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abhd16a (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ABHD16A (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ABHD16A (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abhd16a (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in ABHD16A
46 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 6p25.3-12.3(chr6:156974-46789291)x3 | copy number gain | See cases [RCV000143497] | Chr6:156974..46789291 [GRCh38] Chr6:156974..46757028 [GRCh37] Chr6:101974..46864987 [NCBI36] Chr6:6p25.3-12.3 |
pathogenic |
NM_021160.3(ABHD16A):c.1307+8_1307+11dup | microsatellite | not provided [RCV003312646] | Chr6:31688237..31688238 [GRCh38] Chr6:31656014..31656015 [GRCh37] Chr6:6p21.33 |
likely benign |
NM_021160.3(ABHD16A):c.1236G>A (p.Ala412=) | single nucleotide variant | not provided [RCV003312647] | Chr6:31688737 [GRCh38] Chr6:31656514 [GRCh37] Chr6:6p21.33 |
benign |
GRCh37/hg19 6p21.33(chr6:31384577-31902308)x3 | copy number gain | See cases [RCV000448679] | Chr6:31384577..31902308 [GRCh37] Chr6:6p21.33 |
uncertain significance |
GRCh37/hg19 6p25.3-q27(chr6:156975-170919482)x3 | copy number gain | See cases [RCV000512067] | Chr6:156975..170919482 [GRCh37] Chr6:6p25.3-q27 |
pathogenic |
GRCh37/hg19 6p25.3-q27(chr6:156975-170919482) | copy number gain | See cases [RCV000510595] | Chr6:156975..170919482 [GRCh37] Chr6:6p25.3-q27 |
pathogenic |
NM_021160.3(ABHD16A):c.459C>A (p.Phe153Leu) | single nucleotide variant | Inborn genetic diseases [RCV003244080] | Chr6:31693403 [GRCh38] Chr6:31661180 [GRCh37] Chr6:6p21.33 |
uncertain significance |
GRCh37/hg19 6p25.3-q27(chr6:108666-170980171)x3 | copy number gain | not provided [RCV000745403] | Chr6:108666..170980171 [GRCh37] Chr6:6p25.3-q27 |
pathogenic |
GRCh37/hg19 6p25.3-q27(chr6:60107-171054786)x3 | copy number gain | not provided [RCV000745400] | Chr6:60107..171054786 [GRCh37] Chr6:6p25.3-q27 |
pathogenic |
GRCh37/hg19 6p25.3-q27(chr6:165632-170919470)x3 | copy number gain | not provided [RCV000745404] | Chr6:165632..170919470 [GRCh37] Chr6:6p25.3-q27 |
pathogenic |
GRCh37/hg19 6p22.1-21.32(chr6:28130359-32108367)x3 | copy number gain | not provided [RCV000745592] | Chr6:28130359..32108367 [GRCh37] Chr6:6p22.1-21.32 |
uncertain significance |
GRCh37/hg19 6p22.1-q14.1(chr6:29455465-81447367) | copy number gain | not provided [RCV000767714] | Chr6:29455465..81447367 [GRCh37] Chr6:6p22.1-q14.1 |
pathogenic |
GRCh37/hg19 6p21.33-21.31(chr6:31036397-34088832)x3 | copy number gain | not provided [RCV001005791] | Chr6:31036397..34088832 [GRCh37] Chr6:6p21.33-21.31 |
likely pathogenic |
NC_000006.11:g.(?_30695893)_(31937492_?)dup | duplication | not provided [RCV003107453] | Chr6:30695893..31937492 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.1370G>A (p.Arg457Gln) | single nucleotide variant | Complex hereditary spastic paraplegia [RCV001568339]|Spastic paraplegia 86, autosomal recessive [RCV001826349] | Chr6:31688041 [GRCh38] Chr6:31655818 [GRCh37] Chr6:6p21.33 |
pathogenic |
NM_021160.3(ABHD16A):c.340C>T (p.Arg114Ter) | single nucleotide variant | Complex hereditary spastic paraplegia [RCV001568340]|Spastic paraplegia 86, autosomal recessive [RCV001826350] | Chr6:31700945 [GRCh38] Chr6:31668722 [GRCh37] Chr6:6p21.33 |
pathogenic |
NM_021160.3(ABHD16A):c.1226T>G (p.Leu409Arg) | single nucleotide variant | Spastic paraplegia 86, autosomal recessive [RCV001827482]|Spastic paraplegia [RCV001720321] | Chr6:31688747 [GRCh38] Chr6:31656524 [GRCh37] Chr6:6p21.33 |
pathogenic|uncertain significance |
NM_021160.3(ABHD16A):c.1456del (p.Tyr486fs) | deletion | Autosomal recessive complex spastic paraplegia [RCV001723249] | Chr6:31687732 [GRCh38] Chr6:31655509 [GRCh37] Chr6:6p21.33 |
likely pathogenic |
NM_021160.3(ABHD16A):c.353G>A (p.Arg118His) | single nucleotide variant | Spastic paraplegia 86, autosomal recessive [RCV001827481]|Spastic paraplegia [RCV001720320] | Chr6:31697024 [GRCh38] Chr6:31664801 [GRCh37] Chr6:6p21.33 |
pathogenic|uncertain significance |
NM_021160.3(ABHD16A):c.1333C>T (p.Arg445Ter) | single nucleotide variant | Spastic paraplegia [RCV001720322] | Chr6:31688078 [GRCh38] Chr6:31655855 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.573del (p.Thr192fs) | deletion | Spastic paraplegia [RCV001720323] | Chr6:31693080 [GRCh38] Chr6:31660857 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.362A>T (p.Asn121Ile) | single nucleotide variant | Spastic paraplegia 86, autosomal recessive [RCV001827483]|Spastic paraplegia [RCV001720324] | Chr6:31697015 [GRCh38] Chr6:31664792 [GRCh37] Chr6:6p21.33 |
pathogenic|uncertain significance |
NM_021160.3(ABHD16A):c.755G>A (p.Arg252Gln) | single nucleotide variant | Spastic paraplegia [RCV001720325] | Chr6:31691667 [GRCh38] Chr6:31659444 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.742T>A (p.Cys248Ser) | single nucleotide variant | Inborn genetic diseases [RCV004683822] | Chr6:31691680 [GRCh38] Chr6:31659457 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.461G>A (p.Arg154Gln) | single nucleotide variant | Inborn genetic diseases [RCV002901090] | Chr6:31693401 [GRCh38] Chr6:31661178 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.19T>C (p.Cys7Arg) | single nucleotide variant | Neurodevelopmental disorder [RCV002277676] | Chr6:31703263 [GRCh38] Chr6:31671040 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NC_000006.11:g.28005012_31683185del | deletion | Megacolon [RCV001290055] | Chr6:28005012..31683185 [GRCh37] Chr6:6p22.1-21.33 |
likely pathogenic |
GRCh37/hg19 6p21.33(chr6:31384577-31902308) | copy number gain | not specified [RCV002053564] | Chr6:31384577..31902308 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.835C>T (p.Gln279Ter) | single nucleotide variant | Spastic paraplegia 86, autosomal recessive [RCV001834545] | Chr6:31691587 [GRCh38] Chr6:31659364 [GRCh37] Chr6:6p21.33 |
pathogenic |
NC_000006.11:g.(?_30695893)_(36953949_?)dup | duplication | Proteasome-associated autoinflammatory syndrome 1 [RCV003113679] | Chr6:30695893..36953949 [GRCh37] Chr6:6p21.33-21.2 |
uncertain significance |
NM_021160.3(ABHD16A):c.751C>T (p.Arg251Cys) | single nucleotide variant | Inborn genetic diseases [RCV003262356] | Chr6:31691671 [GRCh38] Chr6:31659448 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.1453A>G (p.Ile485Val) | single nucleotide variant | Inborn genetic diseases [RCV002779488] | Chr6:31687735 [GRCh38] Chr6:31655512 [GRCh37] Chr6:6p21.33 |
likely benign |
NM_021160.3(ABHD16A):c.539T>C (p.Val180Ala) | single nucleotide variant | Inborn genetic diseases [RCV002732076] | Chr6:31693114 [GRCh38] Chr6:31660891 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.71G>C (p.Arg24Thr) | single nucleotide variant | Inborn genetic diseases [RCV002777970] | Chr6:31703211 [GRCh38] Chr6:31670988 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.352C>T (p.Arg118Cys) | single nucleotide variant | Inborn genetic diseases [RCV002687818] | Chr6:31697025 [GRCh38] Chr6:31664802 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.1573C>T (p.Arg525Trp) | single nucleotide variant | Inborn genetic diseases [RCV002692269] | Chr6:31687518 [GRCh38] Chr6:31655295 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.1448-4C>G | single nucleotide variant | Inborn genetic diseases [RCV002803268] | Chr6:31687744 [GRCh38] Chr6:31655521 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.1501C>T (p.Arg501Cys) | single nucleotide variant | Inborn genetic diseases [RCV002873295] | Chr6:31687687 [GRCh38] Chr6:31655464 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.652C>T (p.Arg218Cys) | single nucleotide variant | Inborn genetic diseases [RCV002875386] | Chr6:31691893 [GRCh38] Chr6:31659670 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.1334G>A (p.Arg445Gln) | single nucleotide variant | Inborn genetic diseases [RCV002641191] | Chr6:31688077 [GRCh38] Chr6:31655854 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.1636C>T (p.Pro546Ser) | single nucleotide variant | Inborn genetic diseases [RCV002960507] | Chr6:31687253 [GRCh38] Chr6:31655030 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.373C>T (p.Arg125Trp) | single nucleotide variant | Inborn genetic diseases [RCV003195767] | Chr6:31697004 [GRCh38] Chr6:31664781 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.655C>T (p.Arg219Trp) | single nucleotide variant | Inborn genetic diseases [RCV003184580] | Chr6:31691890 [GRCh38] Chr6:31659667 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.374G>A (p.Arg125Gln) | single nucleotide variant | Inborn genetic diseases [RCV003174140] | Chr6:31697003 [GRCh38] Chr6:31664780 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.523C>T (p.Pro175Ser) | single nucleotide variant | Inborn genetic diseases [RCV003215667] | Chr6:31693130 [GRCh38] Chr6:31660907 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.1465T>C (p.Trp489Arg) | single nucleotide variant | ABHD16A-related disorder [RCV003405779] | Chr6:31687723 [GRCh38] Chr6:31655500 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.551G>T (p.Arg184Leu) | single nucleotide variant | not provided [RCV003431759] | Chr6:31693102 [GRCh38] Chr6:31660879 [GRCh37] Chr6:6p21.33 |
likely benign |
NM_021160.3(ABHD16A):c.260A>G (p.Tyr87Cys) | single nucleotide variant | Spastic paraplegia 86, autosomal recessive [RCV003458943] | Chr6:31701025 [GRCh38] Chr6:31668802 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.1381G>C (p.Val461Leu) | single nucleotide variant | Inborn genetic diseases [RCV004422985] | Chr6:31687890 [GRCh38] Chr6:31655667 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.1528G>A (p.Asp510Asn) | single nucleotide variant | Inborn genetic diseases [RCV004422990] | Chr6:31687660 [GRCh38] Chr6:31655437 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.233C>T (p.Ala78Val) | single nucleotide variant | Inborn genetic diseases [RCV004422994] | Chr6:31701297 [GRCh38] Chr6:31669074 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.407G>A (p.Arg136Gln) | single nucleotide variant | Inborn genetic diseases [RCV004423005] | Chr6:31696970 [GRCh38] Chr6:31664747 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.100A>G (p.Thr34Ala) | single nucleotide variant | Inborn genetic diseases [RCV004422974] | Chr6:31703182 [GRCh38] Chr6:31670959 [GRCh37] Chr6:6p21.33 |
likely benign |
NM_021160.3(ABHD16A):c.85G>C (p.Val29Leu) | single nucleotide variant | ABHD16A-related disorder [RCV003951943] | Chr6:31703197 [GRCh38] Chr6:31670974 [GRCh37] Chr6:6p21.33 |
likely benign |
NM_021160.3(ABHD16A):c.77C>T (p.Pro26Leu) | single nucleotide variant | Inborn genetic diseases [RCV004423023] | Chr6:31703205 [GRCh38] Chr6:31670982 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.22G>A (p.Val8Ile) | single nucleotide variant | not provided [RCV003886928] | Chr6:31703260 [GRCh38] Chr6:31671037 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.568C>T (p.Arg190Trp) | single nucleotide variant | ABHD16A-related disorder [RCV003921545] | Chr6:31693085 [GRCh38] Chr6:31660862 [GRCh37] Chr6:6p21.33 |
likely benign |
NM_021160.3(ABHD16A):c.1174C>T (p.Pro392Ser) | single nucleotide variant | Inborn genetic diseases [RCV004422979] | Chr6:31689027 [GRCh38] Chr6:31656804 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.532C>T (p.Arg178Trp) | single nucleotide variant | Inborn genetic diseases [RCV004423009] | Chr6:31693121 [GRCh38] Chr6:31660898 [GRCh37] Chr6:6p21.33 |
likely benign |
NM_021160.3(ABHD16A):c.406C>T (p.Arg136Trp) | single nucleotide variant | Inborn genetic diseases [RCV004423003] | Chr6:31696971 [GRCh38] Chr6:31664748 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.1233C>T (p.Asn411=) | single nucleotide variant | not provided [RCV003886115] | Chr6:31688740 [GRCh38] Chr6:31656517 [GRCh37] Chr6:6p21.33 |
likely benign |
NM_021160.3(ABHD16A):c.584C>A (p.Thr195Asn) | single nucleotide variant | Inborn genetic diseases [RCV004667408] | Chr6:31693069 [GRCh38] Chr6:31660846 [GRCh37] Chr6:6p21.33 |
likely benign |
NM_021160.3(ABHD16A):c.1559G>A (p.Ser520Asn) | single nucleotide variant | Inborn genetic diseases [RCV004667494] | Chr6:31687532 [GRCh38] Chr6:31655309 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NC_000006.11:g.(?_31631971)_(31895135_?)del | deletion | not provided [RCV004578802] | Chr6:31631971..31895135 [GRCh37] Chr6:6p21.33 |
pathogenic |
NC_000006.11:g.(?_31620520)_(31937492_?)del | deletion | not provided [RCV004578883] | Chr6:31620520..31937492 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.949G>A (p.Gly317Arg) | single nucleotide variant | Inborn genetic diseases [RCV004674991] | Chr6:31690086 [GRCh38] Chr6:31657863 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.639G>A (p.Ala213=) | single nucleotide variant | not provided [RCV004575025] | Chr6:31691906 [GRCh38] Chr6:31659683 [GRCh37] Chr6:6p21.33 |
likely benign |
NM_021160.3(ABHD16A):c.616C>G (p.Gln206Glu) | single nucleotide variant | Inborn genetic diseases [RCV004674856] | Chr6:31693037 [GRCh38] Chr6:31660814 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.1378C>T (p.Arg460Trp) | single nucleotide variant | Inborn genetic diseases [RCV004675065] | Chr6:31687893 [GRCh38] Chr6:31655670 [GRCh37] Chr6:6p21.33 |
uncertain significance |
NM_021160.3(ABHD16A):c.1307+1G>A | single nucleotide variant | Spastic paraplegia 86, autosomal recessive [RCV004765425] | likely pathogenic | |
GRCh37/hg19 6p21.33(chr6:31630124-31657924)x1 | copy number loss | Poirier-Bienvenu neurodevelopmental syndrome [RCV004767742] | Chr6:31630124..31657924 [GRCh37] Chr6:6p21.33 |
likely pathogenic |
The detailed report is available here: | Full Report | CSV | TAB | Printer | ||||
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
The following QTLs overlap with this region. | Full Report | CSV | TAB | Printer | Gviewer |
D6S1938 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
WI-10341 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
NIB1238 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
RH1536 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
D6S1165E |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
A002L14 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||
RH93334 |
|
adipose tissue
|
alimentary part of gastrointestinal system
|
appendage
|
circulatory system
|
ectoderm
|
endocrine system
|
endoderm
|
entire extraembryonic component
|
exocrine system
|
hemolymphoid system
|
hepatobiliary system
|
integumental system
|
mesenchyme
|
mesoderm
|
musculoskeletal system
|
nervous system
|
pharyngeal arch
|
renal system
|
reproductive system
|
respiratory system
|
sensory system
|
visual system
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1204 | 2439 | 2788 | 2253 | 4974 | 1726 | 2351 | 6 | 624 | 1951 | 465 | 2270 | 7306 | 6472 | 53 | 3734 | 1 | 852 | 1744 | 1617 | 174 | 1 |
Ensembl Acc Id: | ENST00000395952 ⟹ ENSP00000379282 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000440843 ⟹ ENSP00000410347 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000468037 ⟹ ENSP00000417566 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000468205 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000471644 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000474007 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000475742 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000477016 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000477462 ⟹ ENSP00000418331 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000482224 ⟹ ENSP00000419742 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000490209 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000492084 ⟹ ENSP00000420585 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000492899 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000495769 ⟹ ENSP00000418170 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000496579 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000498420 ⟹ ENSP00000420628 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_001177515 ⟹ NP_001170986 | ||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NM_021160 ⟹ NP_066983 | ||||||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NR_033488 | ||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||
Type: | NON-CODING | ||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NR_033489 | ||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||
Type: | NON-CODING | ||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NP_066983 ⟸ NM_021160 |
- Peptide Label: | isoform a |
- UniProtKB: | Q8WYH0 (UniProtKB/Swiss-Prot), Q5SRR2 (UniProtKB/Swiss-Prot), Q5SRR1 (UniProtKB/Swiss-Prot), B7Z4R6 (UniProtKB/Swiss-Prot), A2BEY3 (UniProtKB/Swiss-Prot), Q9NW33 (UniProtKB/Swiss-Prot), O95870 (UniProtKB/Swiss-Prot), A0A1U9X777 (UniProtKB/TrEMBL), A8K0A4 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | NP_001170986 ⟸ NM_001177515 |
- Peptide Label: | isoform b |
- UniProtKB: | A8K0A4 (UniProtKB/TrEMBL) |
- Sequence: |
Ensembl Acc Id: | ENSP00000418331 ⟸ ENST00000477462 |
Ensembl Acc Id: | ENSP00000420585 ⟸ ENST00000492084 |
Ensembl Acc Id: | ENSP00000417566 ⟸ ENST00000468037 |
Ensembl Acc Id: | ENSP00000410347 ⟸ ENST00000440843 |
Ensembl Acc Id: | ENSP00000418170 ⟸ ENST00000495769 |
Ensembl Acc Id: | ENSP00000419742 ⟸ ENST00000482224 |
Ensembl Acc Id: | ENSP00000420628 ⟸ ENST00000498420 |
Ensembl Acc Id: | ENSP00000379282 ⟸ ENST00000395952 |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-O95870-F1-model_v2 | AlphaFold | O95870 | 1-558 | view protein structure |
RGD ID: | 6872582 | ||||||||
Promoter ID: | EPDNEW_H9456 | ||||||||
Type: | multiple initiation site | ||||||||
Name: | ABHD16A_2 | ||||||||
Description: | abhydrolase domain containing 16A | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Alternative Promoters: | null; see alsoEPDNEW_H9457 EPDNEW_H9458 EPDNEW_H9459 | ||||||||
Experiment Methods: | Single-end sequencing.; Paired-end sequencing. | ||||||||
Position: |
|
RGD ID: | 6872584 | ||||||||
Promoter ID: | EPDNEW_H9457 | ||||||||
Type: | initiation region | ||||||||
Name: | ABHD16A_3 | ||||||||
Description: | abhydrolase domain containing 16A | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Alternative Promoters: | null; see alsoEPDNEW_H9456 EPDNEW_H9458 EPDNEW_H9459 | ||||||||
Experiment Methods: | Single-end sequencing.; Paired-end sequencing. | ||||||||
Position: |
|
RGD ID: | 6872586 | ||||||||
Promoter ID: | EPDNEW_H9458 | ||||||||
Type: | initiation region | ||||||||
Name: | ABHD16A_4 | ||||||||
Description: | abhydrolase domain containing 16A | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Alternative Promoters: | null; see alsoEPDNEW_H9456 EPDNEW_H9457 EPDNEW_H9459 | ||||||||
Experiment Methods: | Single-end sequencing.; Paired-end sequencing. | ||||||||
Position: |
|
RGD ID: | 6872588 | ||||||||
Promoter ID: | EPDNEW_H9459 | ||||||||
Type: | initiation region | ||||||||
Name: | ABHD16A_1 | ||||||||
Description: | abhydrolase domain containing 16A | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Alternative Promoters: | null; see alsoEPDNEW_H9456 EPDNEW_H9457 EPDNEW_H9458 | ||||||||
Experiment Methods: | Single-end sequencing.; Paired-end sequencing. | ||||||||
Position: |
|
RGD ID: | 6803799 | ||||||||
Promoter ID: | HG_KWN:52967 | ||||||||
Type: | Non-CpG | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | K562, Lymphoblastoid | ||||||||
Transcripts: | OTTHUMT00000076347, OTTHUMT00000076349, OTTHUMT00000144878 | ||||||||
Position: |
|
RGD ID: | 6803806 | ||||||||
Promoter ID: | HG_KWN:52968 | ||||||||
Type: | Non-CpG | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | K562 | ||||||||
Transcripts: | OTTHUMT00000076348, OTTHUMT00000268007 | ||||||||
Position: |
|
RGD ID: | 6803796 | ||||||||
Promoter ID: | HG_KWN:52969 | ||||||||
Type: | Non-CpG | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | K562 | ||||||||
Transcripts: | OTTHUMT00000076346, OTTHUMT00000268006 | ||||||||
Position: |
|
RGD ID: | 6812909 | ||||||||
Promoter ID: | HG_ACW:67969 | ||||||||
Type: | Non-CpG | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | K562 | ||||||||
Transcripts: | BAT5.GAPR07 | ||||||||
Position: |
|
RGD ID: | 6804578 | ||||||||
Promoter ID: | HG_KWN:52971 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4 | ||||||||
Transcripts: | ENST00000375842, NM_001177515, NR_033488, NR_033489, OTTHUMT00000076344, OTTHUMT00000076345, OTTHUMT00000268005, UC010JTC.1 | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:13921 | AgrOrtholog |
COSMIC | ABHD16A | COSMIC |
Ensembl Genes | ENSG00000204427 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
ENSG00000206403 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
ENSG00000224552 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
ENSG00000230475 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
ENSG00000231488 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
ENSG00000235676 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
ENSG00000236063 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Ensembl Transcript | ENST00000395952 | ENTREZGENE |
ENST00000395952.8 | UniProtKB/Swiss-Prot | |
ENST00000413853.6 | UniProtKB/TrEMBL | |
ENST00000414591.5 | UniProtKB/TrEMBL | |
ENST00000422404.5 | UniProtKB/TrEMBL | |
ENST00000422411.5 | UniProtKB/TrEMBL | |
ENST00000429735.6 | UniProtKB/TrEMBL | |
ENST00000431671.5 | UniProtKB/TrEMBL | |
ENST00000432617.6 | UniProtKB/TrEMBL | |
ENST00000440799.5 | UniProtKB/TrEMBL | |
ENST00000440843 | ENTREZGENE | |
ENST00000440843.2 | UniProtKB/Swiss-Prot | |
ENST00000444818.6 | UniProtKB/TrEMBL | |
ENST00000446366.5 | UniProtKB/TrEMBL | |
ENST00000446529.6 | UniProtKB/Swiss-Prot | |
ENST00000457366.6 | UniProtKB/TrEMBL | |
ENST00000468037.1 | UniProtKB/TrEMBL | |
ENST00000477462.5 | UniProtKB/TrEMBL | |
ENST00000482224.5 | UniProtKB/TrEMBL | |
ENST00000492084 | ENTREZGENE | |
ENST00000492084.5 | UniProtKB/TrEMBL | |
ENST00000495769 | ENTREZGENE | |
ENST00000495769.5 | UniProtKB/TrEMBL | |
ENST00000498420.5 | UniProtKB/TrEMBL | |
ENST00000548592.1 | UniProtKB/Swiss-Prot | |
ENST00000549722.1 | UniProtKB/Swiss-Prot | |
ENST00000549853.1 | UniProtKB/Swiss-Prot | |
ENST00000550556.1 | UniProtKB/Swiss-Prot | |
ENST00000551038.1 | UniProtKB/Swiss-Prot | |
ENST00000552042.1 | UniProtKB/Swiss-Prot | |
Gene3D-CATH | 3.40.50.1820 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
GTEx | ENSG00000204427 | GTEx |
ENSG00000206403 | GTEx | |
ENSG00000224552 | GTEx | |
ENSG00000230475 | GTEx | |
ENSG00000231488 | GTEx | |
ENSG00000235676 | GTEx | |
ENSG00000236063 | GTEx | |
HGNC ID | HGNC:13921 | ENTREZGENE |
Human Proteome Map | ABHD16A | Human Proteome Map |
InterPro | AB_hydrolase | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
AB_hydrolase_1 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
ABHD16_N | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
KEGG Report | hsa:7920 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
NCBI Gene | 7920 | ENTREZGENE |
OMIM | 142620 | OMIM |
PANTHER | ALPHA/BETA HYDROLASE DOMAIN-CONTAINING PROTEIN | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
PTHR12277:SF54 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Pfam | ABHD16_N | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
Abhydrolase_1 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
PharmGKB | PA25266 | PharmGKB |
Superfamily-SCOP | SSF53474 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
UniProt | A0A0G2JI89_HUMAN | UniProtKB/TrEMBL |
A0A0G2JJD3_HUMAN | UniProtKB/TrEMBL | |
A0A1U9X777 | ENTREZGENE, UniProtKB/TrEMBL | |
A2BEY3 | ENTREZGENE | |
A8K0A4 | ENTREZGENE, UniProtKB/TrEMBL | |
ABHGA_HUMAN | UniProtKB/Swiss-Prot | |
B3KNX9_HUMAN | UniProtKB/TrEMBL | |
B7Z4R6 | ENTREZGENE | |
F2Z3G6_HUMAN | UniProtKB/TrEMBL | |
F2Z3H2_HUMAN | UniProtKB/TrEMBL | |
F2Z3Q3_HUMAN | UniProtKB/TrEMBL | |
O95870 | ENTREZGENE | |
Q5SRR1 | ENTREZGENE | |
Q5SRR2 | ENTREZGENE | |
Q8WYH0 | ENTREZGENE | |
Q9NW33 | ENTREZGENE | |
UniProt Secondary | A2BEY3 | UniProtKB/Swiss-Prot |
B7Z4R6 | UniProtKB/Swiss-Prot | |
Q5SRR1 | UniProtKB/Swiss-Prot | |
Q5SRR2 | UniProtKB/Swiss-Prot | |
Q8WYH0 | UniProtKB/Swiss-Prot | |
Q9NW33 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2020-01-28 | ABHD16A | abhydrolase domain containing 16A, phospholipase | ABHD16A | abhydrolase domain containing 16A | Symbol and/or name change | 5135510 | APPROVED |
2011-07-27 | ABHD16A | abhydrolase domain containing 16A | BAT5 | HLA-B associated transcript 5 | Symbol and/or name change | 5135510 | APPROVED |